Danaher Corporation (DHR)

Last Price:  

Company Description

Danaher Corporation is a global science and technology innovator committed to helping customers solve complex challenges and improving quality of life around the world. It operates through the following business segments : Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial Technologies. Danaher's instrument business offers test, measurement and monitoring products that are used in electronic design, manufacturing and advanced technology development, as well as for installation, service and maintenance of electrical, electronic & calibration applications. The company's commercial petroleum business is a leading worldwide provider of solutions and services focused on fuel dispensing, remote fuel management & environmental compliance. It's Industrial Technologies segment solutions help protect the world's food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines. Danaher is headquartered in Washington, DC.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $17.91B
Net Income (Most Recent Fiscal Year) $3.01B
PE Ratio (Current Year Earnings Estimate) 37.60
PE Ratio (Trailing 12 Months) 41.75
PEG Ratio (Long Term Growth Estimate) 3.23
Price to Sales Ratio (Trailing 12 Months) 7.47
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 4.42
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 33.12
Pre-Tax Margin (Trailing 12 Months) 18.90%
Net Margin (Trailing 12 Months) 17.73%
Return on Equity (Trailing 12 Months) 11.88%
Return on Assets (Trailing 12 Months) 5.53%
Current Ratio (Most Recent Fiscal Quarter) 2.20
Quick Ratio (Most Recent Fiscal Quarter) 1.74
Debt to Common Equity (Most Recent Fiscal Quarter) 0.68
Inventory Turnover (Trailing 12 Months) 3.83
Book Value per Share (Most Recent Fiscal Quarter) $39.93
Earnings per Share (Most Recent Fiscal Quarter) $1.44
Earnings per Share (Most Recent Fiscal Year) $4.42
Diluted Earnings per Share (Trailing 12 Months) $4.67
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding 709.41M
Free Float 626.41M
Market Capitalization $146.00B
Average Volume (Last 20 Days) 2.00M
Beta (Past 60 Months) 0.91
Percentage Held By Insiders (Latest Annual Proxy Report) 11.70%
Percentage Held By Institutions (Latest 13F Reports) 78.01%
Annual Dividend (Based on Last Quarter) $0.72
Dividend Yield (Based on Last Quarter) 0.35%